Apollo Hospitals has tied up with the US-based AliveCor Inc. to provide mobile electrocardiogram (ECG) devices to patients suffering from arrhythmias.
The heart-monitor device, approved by the US Food and Drug Administration (USFDA), would be sold to patients for ₹12,000 to keep a tab on their heartbeat, Dr Pratap C Reddy, Chairman, Apollo Hospitals, told newspersons here on Tuesday.
The device is smart phone-enabled and compatible with global standards.
“It can wirelessly record, display, store and transfer hear rate and single channel electrocardiogram to a doctor remotely located,’’ said Euan Thomson, President and Chief Executive Officer, AliveCor.
According to Sangeetha Reddy, Joint Managing Director, Apollo Hospitals, the monitor can be connected to a central round-the-clock station for interpretation of data/reading of the report for a monthly subscription of ₹1,000 for the first three months.
The charges for subsequent period were being worked out, she said.